HOME >> BIOLOGY >> NEWS
Better Binding Through Chemistry

March 2, 1999--Many biological processes are triggered by the interaction, or binding, of molecules. So important is this motif in nature that numerous strategies have evolved to ensure the proper union of molecules. HHMI investigator Gerald Crabtree and colleagues at Stanford University have borrowed a trick used by microbes and cells in the immune system to engineer drug molecules that bind to their targets more effectively.

More importantly, says Crabtree, the approach also offers a new solution to the frustrating problem of developing small molecule drugs that can prevent two large proteins from binding to one another.

"Small molecules have not been very successful at inhibiting protein-protein interactions because the protein surfaces are huge," said Crabtree. "They are like molecular football fields, and using a small molecule to prevent these surfaces from coming together is like putting a pea down on a football field."

Crabtree and Stanford colleagues Roger Briesewitz, Gregory Ray and Thomas Wandless leveled the playing field by increasing the size of the small molecule inhibitor. They did this by chemically attaching the inhibitor to another small linker molecule that binds tightly to a much bigger "presenting" protein that exists naturally in the human body.

In essence, the combination of small drug molecule, linker and big protein allows the drug candidate to borrow the huge surface area of the presenting protein, making it appear to its target as if it is much bigger and stickier.

"Using a presenting protein is like bringing in a molecular wrecking ball instead of a pea," says Crabtree, because you "create a molecule with so much surface area that it now has a chance of out-competing the normal protein-protein interaction that you are trying to disrupt."

Crabtree, who has spent more than a decade deciphering the signals that turn on the
'"/>

Contact: Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute
2-Mar-1999


Page: 1 2 3

Related biology news :

1. Better living through urban ecology
2. Better techniques needed to predict earthquake hazards, UC study finds
3. Better model of cancer development sheds light on potential angiogenesis target
4. Natural Science and Public Health: Prescription for a Better Environment
5. Better computer modeling provides a new look at large biomolecules
6. UF nutritionist: Better to vow to eat healthy for new year
7. Better "bugs" lead to cheaper ethanol from biomass
8. Diet and cancer prevention: a sampler of story ideas for 5-a-Day for Better Health Week
9. Some Atlantic Coast Beaches Are Shrinking While Floridas Beaches Better Off Than Most
10. New Polyester Products Perform Better And Are Easy To Recycle
11. Urine Tests Will Do Better Than Pelvic Exams To Save Teens From Serious Effects Of Sexually Transmitted Diseases, UCSF Analysis Shows

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2019)... ... ... In the wake of the success of IBBL’s international ... was launched in July 2018, in an agreement between IBBL, the International Society ... Association (BBCMBA). The one-year pilot programme offered two testing schemes: ‘DNA quantification and ...
(Date:3/29/2019)... ... March 29, 2019 , ... GenCure has selected G-CON Manufacturing, ... facility. The new facility, which will anchor the VelocityTX innovation center in San ... manufacturing capabilities to support clinical cell therapy trials. GenCure is a subsidiary of ...
(Date:3/26/2019)... ... March 26, 2019 , ... ... introduce the four recipients of the Society's 2019 Outstanding Achievement Award, Outstanding New ... will be presented at the ASGCT 22nd Annual Meeting . , Outstanding ...
Breaking Biology News(10 mins):
(Date:4/10/2019)... ... April 10, 2019 , ... ... locked into multiple agreements to help companies advance their innovations to clinical ... ranging from synthetic biology companies that are gene editing therapeutic cells for ...
(Date:4/9/2019)... ... , ... Sonny Bar Lisa, or Sonny for short, is a quarter horse ... a series of diagnostics, an MRI was performed which revealed Sonny had torn his ... found that VetStem Regenerative Cell Therapy may be a treatment option for ...
(Date:4/8/2019)... SAN FRANCISCO (PRWEB) , ... April 08, 2019 , ... ... to accredited investors a $15 million preferred equity investment in the privately held pharmaceutical ... dysfunction. Its leading drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and ...
(Date:4/4/2019)... ... April 03, 2019 , ... LeadingBiotech, an exclusive ... dialogue, today announces its Boston CEO conference to be held May 28-29, 2019 ... and opportunities with high-level panels and discussions from past, present and future change-makers. ...
Breaking Biology Technology:
Cached News: